Neuroendocrine changes in chronic cardiac failure
Authors:
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 91 (S1) , 13-20
Abstract
Numerous hormonal and neuroendocrine changes have been described in patients with chronic cardiac failure. These affect the balance of vasodilator and vasoconstrictor factors in favour of the latter, to the detriment of the circulation. Whether this is a reaction to central cardiac (haemodynamic) abnormalities, or is an integral part of the syndrome of heart failure, remains to be determined. Catecholamine levels are increased, especially in severe heart failure, and contribute to the vasoconstriction and probably also to lethal ventricular arrhythmias. The renin-angiotensin-aldosterone system (RAAS) is also activated, causing fluid retention and further vasoconstriction. In the earlier stages, some of this increase may be iatrogenic due to the use of loop diuretics or inhibitors of angiotensin converting enzyme, but there is evidence for independent RAAS activation in more severe grades of heart failure. The role of vasoconstrictor peptides such as neuropeptide Y and endothelin is briefly considered. Counterbalancing these are vasodilator peptides, in particular atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP). The possibility of therapeutic interventions to increase circulating natriuretic hormone levels is discussed.Keywords
This publication has 135 references indexed in Scilit:
- C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvesselsBiochemical and Biophysical Research Communications, 1992
- Plasma concentrations of calcitonin gene-related peptide in fluid overloadThe Lancet, 1991
- Gene and precursor structures of human C-type natriuretic peptideBiochemical and Biophysical Research Communications, 1991
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brainBiochemical and Biophysical Research Communications, 1988
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in manLife Sciences, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure.Circulation, 1983
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981